| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5591454 | PFIZER | Method for lowering blood glucose |
Jan, 2014
(10 years ago) | |
| USRE44459 | PFIZER | Method for lowering blood glucose |
Mar, 2019
(5 years ago) | |
Glucotrol Xl is owned by Pfizer.
Glucotrol Xl contains Glipizide.
Glucotrol Xl has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Glucotrol Xl are:
- US5591454
- USRE44459
Glucotrol Xl was authorised for market use on 10 August, 1999.
Glucotrol Xl is available in tablet, extended release;oral dosage forms.
Glucotrol Xl can be used as method of treating hyperglycemia to improve glycemic control in a patient by oral admin of once a day osmotic dosage form of glipizide with polyethylene oxide, hydroxypropylmethylcellulose, cellulose acetate, and sodium chloride, method of use for controlling hyperglycemia by administration of this sustained release dosage form of glipizide.
The generics of Glucotrol Xl are possible to be released after 26 March, 2019.
Drugs and Companies using GLIPIZIDE ingredient
Market Authorisation Date: 10 August, 1999
Treatment: Method of use for controlling hyperglycemia by administration of this sustained release dosage form of glipizide; Method of treating hyperglycemia to improve glycemic control in a patient by oral admi...
Dosage: TABLET, EXTENDED RELEASE;ORAL
GLUCOTROL XL family patents
